Home The Word Brain My Amedeo FAQ Privacy About Flying Publisher   


OLIENA
Language recovery after stroke
App | Video | PDF (278 pp) | Web

  Colorectal Neoplasms

  Free Subscription


Articles published in PLoS One

Retrieve available abstracts of 166 articles:
HTML format
Text format



Single Articles


    January 2018
  1. LIN CY, Lin TH, Chen CC, Chen MC, et al
    Combination chemotherapy with Regorafenib in metastatic colorectal cancer treatment: A single center, retrospective study.
    PLoS One. 2018;13:e0190497.
    PubMed     Text format     Abstract available


  2. FAN F, Wang R, Boulbes DR, Zhang H, et al
    Macrophage conditioned medium promotes colorectal cancer stem cell phenotype via the hedgehog signaling pathway.
    PLoS One. 2018;13:e0190070.
    PubMed     Text format     Abstract available


  3. ZIAI J, Gilbert HN, Foreman O, Eastham-Anderson J, et al
    CD8+ T cell infiltration in breast and colon cancer: A histologic and statistical analysis.
    PLoS One. 2018;13:e0190158.
    PubMed     Text format     Abstract available


  4. ZHANG Y, Liu H, Li L, Ai M, et al
    Correction: Cholecystectomy can increase the risk of colorectal cancer: A meta-analysis of 10 cohort studies.
    PLoS One. 2018;13:e0191587.
    PubMed     Text format     Abstract available


  5. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0191358.
    PubMed     Text format     Abstract available


  6. MUGHINI-GRAS L, Schaapveld M, Kramers J, Mooij S, et al
    Increased colon cancer risk after severe Salmonella infection.
    PLoS One. 2018;13:e0189721.
    PubMed     Text format     Abstract available


  7. MAKONDI PT, Lee CH, Huang CY, Chu CM, et al
    Prediction of novel target genes and pathways involved in bevacizumab-resistant colorectal cancer.
    PLoS One. 2018;13:e0189582.
    PubMed     Text format     Abstract available


  8. GOMES SE, Pereira DM, Roma-Rodrigues C, Fernandes AR, et al
    Convergence of miR-143 overexpression, oxidative stress and cell death in HCT116 human colon cancer cells.
    PLoS One. 2018;13:e0191607.
    PubMed     Text format     Abstract available


  9. SILVA DAS, Tremblay MS, Souza MFM, Mooney M, et al
    Mortality and years of life lost by colorectal cancer attributable to physical inactivity in Brazil (1990-2015): Findings from the Global Burden of Disease Study.
    PLoS One. 2018;13:e0190943.
    PubMed     Text format     Abstract available


  10. LI F, Li Q, Wu X
    Construction and analysis for differentially expressed long non-coding RNAs and MicroRNAs mediated competing endogenous RNA network in colon cancer.
    PLoS One. 2018;13:e0192494.
    PubMed     Text format     Abstract available


  11. CATALANO C, da Silva Filho MI, Frank C, Jiraskova K, et al
    Investigation of single and synergic effects of NLRC5 and PD-L1 variants on the risk of colorectal cancer.
    PLoS One. 2018;13:e0192385.
    PubMed     Text format     Abstract available


  12. HE Y, Penney ME, Negandhi AA, Parfrey PS, et al
    XRCC3 Thr241Met and TYMS variable number tandem repeat polymorphisms are associated with time-to-metastasis in colorectal cancer.
    PLoS One. 2018;13:e0192316.
    PubMed     Text format     Abstract available


  13. SEO IS, Lee HG, Koo B, Koh CS, et al
    Cross detection for odor of metabolic waste between breast and colorectal cancer using canine olfaction.
    PLoS One. 2018;13:e0192629.
    PubMed     Text format     Abstract available


  14. SHETH H, Northwood E, Ulrich CM, Scherer D, et al
    Interaction between polymorphisms in aspirin metabolic pathways, regular aspirin use and colorectal cancer risk: A case-control study in unselected white European populations.
    PLoS One. 2018;13:e0192223.
    PubMed     Text format     Abstract available


  15. FRANZ J, Grunebaum J, Schafer M, Mulac D, et al
    Rhombic organization of microvilli domains found in a cell model of the human intestine.
    PLoS One. 2018;13:e0189970.
    PubMed     Text format     Abstract available


  16. MARCUELLO M, Mayol X, Felipe-Fumero E, Costa J, et al
    Modulation of the colon cancer cell phenotype by pro-inflammatory macrophages: A preclinical model of surgery-associated inflammation and tumor recurrence.
    PLoS One. 2018;13:e0192958.
    PubMed     Text format     Abstract available


  17. CHOI JW, Kim DK, Kim JK, Lee EJ, et al
    A retrospective analysis on the relationship between intraoperative hypothermia and postoperative ileus after laparoscopic colorectal surgery.
    PLoS One. 2018;13:e0190711.
    PubMed     Text format     Abstract available


  18. GALLERY M, Zhang J, Bradley DP, Brauer P, et al
    A monomethyl auristatin E-conjugated antibody to guanylyl cyclase C is cytotoxic to target-expressing cells in vitro and in vivo.
    PLoS One. 2018;13:e0191046.
    PubMed     Text format     Abstract available


  19. JUNG YS, Park CH, Kim NH, Park JH, et al
    Clinical risk stratification model for advanced colorectal neoplasia in persons with negative fecal immunochemical test results.
    PLoS One. 2018;13:e0191125.
    PubMed     Text format     Abstract available


  20. WANG H, Du K, Qu J, Chandarana H, et al
    Dosimetric evaluation of magnetic resonance-generated synthetic CT for radiation treatment of rectal cancer.
    PLoS One. 2018;13:e0190883.
    PubMed     Text format     Abstract available


  21. SCHIRRIPA M, Zhang W, Yang D, Cao S, et al
    NOS2 polymorphisms in prediction of benefit from first-line chemotherapy in metastatic colorectal cancer patients.
    PLoS One. 2018;13:e0193640.
    PubMed     Text format     Abstract available


  22. MARLICZ W, Poniewierska-Baran A, Rzeszotek S, Bartoszewski R, et al
    A novel potential role of pituitary gonadotropins in the pathogenesis of human colorectal cancer.
    PLoS One. 2018;13:e0189337.
    PubMed     Text format     Abstract available


  23. ARELAKI S, Arampatzioglou A, Kambas K, Sivridis E, et al
    Mast cells co-expressing CD68 and inorganic polyphosphate are linked with colorectal cancer.
    PLoS One. 2018;13:e0193089.
    PubMed     Text format     Abstract available


  24. HOF J, Joosten HJ, Havenga K, de Jong KP, et al
    Radiofrequency ablation is beneficial in simultaneous treatment of synchronous liver metastases and primary colorectal cancer.
    PLoS One. 2018;13:e0193385.
    PubMed     Text format     Abstract available


  25. FENG S, Zhou Q, Yang B, Li Q, et al
    The effect of S100A6 on nuclear translocation of CacyBP/SIP in colon cancer cells.
    PLoS One. 2018;13:e0192208.
    PubMed     Text format     Abstract available


  26. JIAO X, Liu W, Mahdessian H, Bryant P, et al
    Recurrent, low-frequency coding variants contributing to colorectal cancer in the Swedish population.
    PLoS One. 2018;13:e0193547.
    PubMed     Text format     Abstract available


  27. ORTIZ-ORTIZ KJ, Tortolero-Luna G, Rios-Motta R, Veintidos-Feliu A, et al
    Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study.
    PLoS One. 2018;13:e0194415.
    PubMed     Text format     Abstract available


  28. HOLM M, Saraswat M, Joenvaara S, Ristimaki A, et al
    Colorectal cancer patients with different C-reactive protein levels and 5-year survival times can be differentiated with quantitative serum proteomics.
    PLoS One. 2018;13:e0195354.
    PubMed     Text format     Abstract available


  29. LU J, Hu X, Meng Y, Zhao H, et al
    The prognosis significance and application value of peritoneal elastic lamina invasion in colon cancer.
    PLoS One. 2018;13:e0194804.
    PubMed     Text format     Abstract available


  30. SULZYC-BIELICKA V, Kolodziejczyk L, Jaczewska S, Bielicki D, et al
    Colorectal cancer and Cryptosporidium spp. infection.
    PLoS One. 2018;13:e0195834.
    PubMed     Text format     Abstract available


  31. PANDE M, Joon A, Brewster AM, Chen WV, et al
    Genetic susceptibility markers for a breast-colorectal cancer phenotype: Exploratory results from genome-wide association studies.
    PLoS One. 2018;13:e0196245.
    PubMed     Text format     Abstract available


  32. LEE MK, Kim NK, Jeon JY
    Effect of the 6-week home-based exercise program on physical activity level and physical fitness in colorectal cancer survivors: A randomized controlled pilot study.
    PLoS One. 2018;13:e0196220.
    PubMed     Text format     Abstract available


  33. ISEKI Y, Shibutani M, Maeda K, Nagahara H, et al
    A new method for evaluating tumor-infiltrating lymphocytes (TILs) in colorectal cancer using hematoxylin and eosin (H-E)-stained tumor sections.
    PLoS One. 2018;13:e0192744.
    PubMed     Text format     Abstract available


  34. MYTE R, Gylling B, Haggstrom J, Schneede J, et al
    One-carbon metabolism biomarkers and genetic variants in relation to colorectal cancer risk by KRAS and BRAF mutation status.
    PLoS One. 2018;13:e0196233.
    PubMed     Text format     Abstract available


  35. OTEGBEYE F, Ojo E, Moreton S, Mackowski N, et al
    Correction: Inhibiting TGF-beta signaling preserves the function of highly activated, in vitro expanded natural killer cells in AML and colon cancer models.
    PLoS One. 2018;13:e0197008.
    PubMed     Text format     Abstract available


  36. KOJIMA K, Nakamura T, Ohbu M, Katoh H, et al
    Cysteine dioxygenase type 1 (CDO1) gene promoter methylation during the adenoma-carcinoma sequence in colorectal cancer.
    PLoS One. 2018;13:e0194785.
    PubMed     Text format     Abstract available


  37. MOLPARIA B, Oliveira G, Wagner JL, Spencer EG, et al
    A feasibility study of colorectal cancer diagnosis via circulating tumor DNA derived CNV detection.
    PLoS One. 2018;13:e0196826.
    PubMed     Text format     Abstract available


  38. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    Correction: The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2018;13:e0197765.
    PubMed     Text format     Abstract available


  39. KUAN TC, Lin PC, Yang SH, Lin CC, et al
    Impact of LINE-1 hypomethylation on the clinicopathological and molecular features of colorectal cancer patients.
    PLoS One. 2018;13:e0197681.
    PubMed     Text format     Abstract available


  40. CHAT-UTHAI N, Vejvisithsakul P, Udommethaporn S, Meesiri P, et al
    Development of ultra-short PCR assay to reveal BRAF V600 mutation status in Thai colorectal cancer tissues.
    PLoS One. 2018;13:e0198795.
    PubMed     Text format     Abstract available


  41. JARZABEK MA, Proctor WR, Vogt J, Desai R, et al
    Interrogation of transcriptomic changes associated with drug-induced hepatic sinusoidal dilatation in colorectal cancer.
    PLoS One. 2018;13:e0198099.
    PubMed     Text format     Abstract available


  42. AWAN R, Al-Maadeed S, Al-Saady R
    Using spectral imaging for the analysis of abnormalities for colorectal cancer: When is it helpful?
    PLoS One. 2018;13:e0197431.
    PubMed     Text format     Abstract available


  43. ALJARBOU F, Almousa N, Bazzi M, Aldaihan S, et al
    The expression of telomere-related proteins and DNA damage response and their association with telomere length in colorectal cancer in Saudi patients.
    PLoS One. 2018;13:e0197154.
    PubMed     Text format     Abstract available


  44. YU Y, Cheng D, Parfrey P, Liu G, et al
    Two functional indel polymorphisms in the promoter region of the Brahma gene (BRM) and disease risk and progression-free survival in colorectal cancer.
    PLoS One. 2018;13:e0198873.
    PubMed     Text format     Abstract available


  45. MESSARITAKIS I, Stogiannitsi M, Koulouridi A, Sfakianaki M, et al
    Evaluation of the detection of Toll-like receptors (TLRs) in cancer development and progression in patients with colorectal cancer.
    PLoS One. 2018;13:e0197327.
    PubMed     Text format     Abstract available


  46. HUHN S, da Silva Filho MI, Sanmuganantham T, Pichulik T, et al
    Coding variants in NOD-like receptors: An association study on risk and survival of colorectal cancer.
    PLoS One. 2018;13:e0199350.
    PubMed     Text format     Abstract available


  47. BERTAUT A, Coudert J, Bengrine L, Dancourt V, et al
    Does mammogram attendance influence participation in cervical and colorectal cancer screening? A prospective study among 1856 French women.
    PLoS One. 2018;13:e0198939.
    PubMed     Text format     Abstract available


  48. SAMRAJ AN, Bertrand KA, Luben R, Khedri Z, et al
    Polyclonal human antibodies against glycans bearing red meat-derived non-human sialic acid N-glycolylneuraminic acid are stable, reproducible, complex and vary between individuals: Total antibody levels are associated with colorectal cancer risk.
    PLoS One. 2018;13:e0197464.
    PubMed     Text format     Abstract available


  49. QUINTANA JM, Anton-Ladislao A, Gonzalez N, Lazaro S, et al
    Predictors of one and two years' mortality in patients with colon cancer: A prospective cohort study.
    PLoS One. 2018;13:e0199894.
    PubMed     Text format     Abstract available


  50. GAVARUZZI T, Sarlo M, Giandomenico F, Rumiati R, et al
    Assessing emotions conveyed and elicited by patient narratives and their impact on intention to participate in colorectal cancer screening: A psychophysiological investigation.
    PLoS One. 2018;13:e0199882.
    PubMed     Text format     Abstract available


  51. PARK J, Kim JH, Park Y, Park SJ, et al
    Resting heart rate is an independent predictor of advanced colorectal adenoma recurrence.
    PLoS One. 2018;13:e0193753.
    PubMed     Text format     Abstract available


  52. DAVIDSEN J, Larsen S, Coskun M, Gogenur I, et al
    The VTI1A-TCF4 colon cancer fusion protein is a dominant negative regulator of Wnt signaling and is transcriptionally regulated by intestinal homeodomain factor CDX2.
    PLoS One. 2018;13:e0200215.
    PubMed     Text format     Abstract available


  53. NODA M, Okayama H, Kofunato Y, Chida S, et al
    Prognostic role of FUT8 expression in relation to p53 status in stage II and III colorectal cancer.
    PLoS One. 2018;13:e0200315.
    PubMed     Text format     Abstract available


  54. INOUE M, Uchida Y, Edagawa M, Hirata M, et al
    The stress response gene ATF3 is a direct target of the Wnt/beta-catenin pathway and inhibits the invasion and migration of HCT116 human colorectal cancer cells.
    PLoS One. 2018;13:e0194160.
    PubMed     Text format     Abstract available


  55. FOSTER CC, Lee AY, Furtado LV, Hart J, et al
    Treatment outcomes and HPV characteristics for an institutional cohort of patients with anal cancer receiving concurrent chemotherapy and intensity-modulated radiation therapy.
    PLoS One. 2018;13:e0194234.
    PubMed     Text format     Abstract available


  56. PERRIER L, Rascle P, Morelle M, Toulmonde M, et al
    The cost-saving effect of centralized histological reviews with soft tissue and visceral sarcomas, GIST, and desmoid tumors: The experiences of the pathologists of the French Sarcoma Group.
    PLoS One. 2018;13:e0193330.
    PubMed     Text format     Abstract available


  57. WALI RK, Bianchi L, Kupfer S, De La Cruz M, et al
    Prevention of colonic neoplasia with polyethylene glycol: A short term randomized placebo-controlled double-blinded trial.
    PLoS One. 2018;13:e0193544.
    PubMed     Text format     Abstract available


  58. PANNUTI A, Filipovic A, Hicks C, Lefkowitz E, et al
    Novel putative drivers revealed by targeted exome sequencing of advanced solid tumors.
    PLoS One. 2018;13:e0194790.
    PubMed     Text format     Abstract available


  59. MOJTABANEZHAD SHARIATPANAHI A, Yassi M, Nouraie M, Sahebkar A, et al
    The importance of stool DNA methylation in colorectal cancer diagnosis: A meta-analysis.
    PLoS One. 2018;13:e0200735.
    PubMed     Text format     Abstract available


  60. GUERCIO BJ, Zhang S, Niedzwiecki D, Li Y, et al
    Associations of artificially sweetened beverage intake with disease recurrence and mortality in stage III colon cancer: Results from CALGB 89803 (Alliance).
    PLoS One. 2018;13:e0199244.
    PubMed     Text format     Abstract available


  61. ATREYA CE, Kubo A, Borno HT, Rosenthal B, et al
    Being Present: A single-arm feasibility study of audio-based mindfulness meditation for colorectal cancer patients and caregivers.
    PLoS One. 2018;13:e0199423.
    PubMed     Text format     Abstract available


  62. TAI YH, Chang WK, Wu HL, Chan MY, et al
    The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0200893.
    PubMed     Text format     Abstract available


  63. CHANG JY, Moon CM, Lee HJ, Yang HJ, et al
    Predictive factors for missed adenoma on repeat colonoscopy in patients with suboptimal bowel preparation on initial colonoscopy: A KASID multicenter study.
    PLoS One. 2018;13:e0195709.
    PubMed     Text format     Abstract available


  64. SAITA C, Yamaguchi T, Horiguchi SI, Yamada R, et al
    Tumor development in Japanese patients with Lynch syndrome.
    PLoS One. 2018;13:e0195572.
    PubMed     Text format     Abstract available


  65. EBELING M, Modig K, Ahlbom A, Rau R, et al
    The effects of increasing longevity and changing incidence on lifetime risk differentials: A decomposition approach.
    PLoS One. 2018;13:e0195307.
    PubMed     Text format     Abstract available


  66. TAKEDA Y, Akiyoshi T, Matsueda K, Fukuoka H, et al
    Skeletal muscle loss is an independent negative prognostic factor in patients with advanced lower rectal cancer treated with neoadjuvant chemoradiotherapy.
    PLoS One. 2018;13:e0195406.
    PubMed     Text format     Abstract available


  67. GHOSH R, Roy S, Franco S
    PARP1 depletion induces RIG-I-dependent signaling in human cancer cells.
    PLoS One. 2018;13:e0194611.
    PubMed     Text format     Abstract available


  68. JANSEN RJ, Alexander BH, Hayes RB, Miller AB, et al
    A mathematical model of case-ascertainment bias: Applied to case-control studies nested within a randomized screening trial.
    PLoS One. 2018;13:e0194608.
    PubMed     Text format     Abstract available


  69. WOLFF A, Bayerlova M, Gaedcke J, Kube D, et al
    A comparative study of RNA-Seq and microarray data analysis on the two examples of rectal-cancer patients and Burkitt Lymphoma cells.
    PLoS One. 2018;13:e0197162.
    PubMed     Text format     Abstract available


  70. BOGACHEV MI, Volkov VY, Markelov OA, Trizna EY, et al
    Fast and simple tool for the quantification of biofilm-embedded cells sub-populations from fluorescent microscopic images.
    PLoS One. 2018;13:e0193267.
    PubMed     Text format     Abstract available


  71. KIM MJ, Hur BY, Lee ES, Park B, et al
    Prediction of lateral pelvic lymph node metastasis in patients with locally advanced rectal cancer with preoperative chemoradiotherapy: Focus on MR imaging findings.
    PLoS One. 2018;13:e0195815.
    PubMed     Text format     Abstract available


  72. BONNET E, Moutet ML, Baulard C, Bacq-Daian D, et al
    Performance comparison of three DNA extraction kits on human whole-exome data from formalin-fixed paraffin-embedded normal and tumor samples.
    PLoS One. 2018;13:e0195471.
    PubMed     Text format     Abstract available


  73. SCHREMBS P, Martin B, Anthuber M, Schenkirsch G, et al
    The prognostic significance of lymph node size in node-positive colon cancer.
    PLoS One. 2018;13:e0201072.
    PubMed     Text format     Abstract available


  74. TAI YH, Chang WK, Wu HL, Chan MY, et al
    Correction: The effect of epidural analgesia on cancer progression in patients with stage IV colorectal cancer after primary tumor resection: A retrospective cohort study.
    PLoS One. 2018;13:e0202192.
    PubMed     Text format     Abstract available


  75. NEERINCX M, Poel D, Sie DLS, van Grieken NCT, et al
    Combination of a six microRNA expression profile with four clinicopathological factors for response prediction of systemic treatment in patients with advanced colorectal cancer.
    PLoS One. 2018;13:e0201809.
    PubMed     Text format     Abstract available


  76. STANILOVA S, Stanilov N, Julianov A, Manolova I, et al
    Transforming growth factor-beta1 gene promoter -509C/T polymorphism in association with expression affects colorectal cancer development and depends on gender.
    PLoS One. 2018;13:e0201775.
    PubMed     Text format     Abstract available


  77. PRENTICE LM, Miller RR, Knaggs J, Mazloomian A, et al
    Formalin fixation increases deamination mutation signature but should not lead to false positive mutations in clinical practice.
    PLoS One. 2018;13:e0196434.
    PubMed     Text format     Abstract available


  78. PAL R, Wei N, Song N, Wu S, et al
    Molecular subtypes of colorectal cancer in pre-clinical models show differential response to targeted therapies: Treatment implications beyond KRAS mutations.
    PLoS One. 2018;13:e0200836.
    PubMed     Text format     Abstract available


  79. DEN BAKKER CM, Anema JR, Zaman AGNM, de Vet HCW, et al
    Prognostic factors for return to work and work disability among colorectal cancer survivors; A systematic review.
    PLoS One. 2018;13:e0200720.
    PubMed     Text format     Abstract available


  80. LYNN H, Sun X, Ayshiev D, Siegler JH, et al
    Single nucleotide polymorphisms in the MYLKP1 pseudogene are associated with increased colon cancer risk in African Americans.
    PLoS One. 2018;13:e0200916.
    PubMed     Text format     Abstract available


  81. KIM JC, Ha YJ, Tak KH, Roh SA, et al
    Opposite functions of GSN and OAS2 on colorectal cancer metastasis, mediating perineural and lymphovascular invasion, respectively.
    PLoS One. 2018;13:e0202856.
    PubMed     Text format     Abstract available


  82. MURCIA O, Juarez M, Rodriguez-Soler M, Hernandez-Illan E, et al
    Colorectal cancer molecular classification using BRAF, KRAS, microsatellite instability and CIMP status: Prognostic implications and response to chemotherapy.
    PLoS One. 2018;13:e0203051.
    PubMed     Text format     Abstract available


  83. DHATCHANA MOORTHY N, Muthu Ramalingam B, Iqbal S, Mohanakrishnan AK, et al
    Novel isothiacalothrixin B analogues exhibit cytotoxic activity on human colon cancer cells in vitro by inducing irreversible DNA damage.
    PLoS One. 2018;13:e0202903.
    PubMed     Text format     Abstract available


  84. DECKER KM, Nugent Z, Lambert P, Biswanger N, et al
    Interval colorectal cancer rates after Hemoccult Sensa and survival by detection mode for individuals diagnosed with colorectal cancer in Winnipeg, Manitoba.
    PLoS One. 2018;13:e0203321.
    PubMed     Text format     Abstract available


  85. SEO MK, Cairns J
    Do cancer biomarkers make targeted therapies cost-effective? A systematic review in metastatic colorectal cancer.
    PLoS One. 2018;13:e0204496.
    PubMed     Text format     Abstract available


  86. MARTIN-MORALES L, Rofes P, Diaz-Rubio E, Llovet P, et al
    Novel genetic mutations detected by multigene panel are associated with hereditary colorectal cancer predisposition.
    PLoS One. 2018;13:e0203885.
    PubMed     Text format     Abstract available


  87. VAN DER WAALS LM, Borel Rinkes IHM, Kranenburg O
    ALDH1A1 expression is associated with poor differentiation, 'right-sidedness' and poor survival in human colorectal cancer.
    PLoS One. 2018;13:e0205536.
    PubMed     Text format     Abstract available


  88. KANG S, Kim BR, Kang MH, Kim DY, et al
    Anti-metastatic effect of metformin via repression of interleukin 6-induced epithelial-mesenchymal transition in human colon cancer cells.
    PLoS One. 2018;13:e0205449.
    PubMed     Text format     Abstract available


  89. SU TC, Chen CY, Tsai WC, Hsu HT, et al
    Cytoplasmic, nuclear, and total PBK/TOPK expression is associated with prognosis in colorectal cancer patients: A retrospective analysis based on immunohistochemistry stain of tissue microarrays.
    PLoS One. 2018;13:e0204866.
    PubMed     Text format     Abstract available


  90. BROWN JC, Rhim AD, Manning SL, Brennan L, et al
    Effects of exercise on circulating tumor cells among patients with resected stage I-III colon cancer.
    PLoS One. 2018;13:e0204875.
    PubMed     Text format     Abstract available



  91. Retraction: Overexpression of Rad51 Predicts Poor Prognosis in Colorectal Cancer: Our Experience with 54 Patients.
    PLoS One. 2018;13:e0206398.
    PubMed     Text format    


  92. CHUN KA, Kocarnik JM, Hardikar SS, Robinson JR, et al
    Leptin gene variants and colorectal cancer risk: Sex-specific associations.
    PLoS One. 2018;13:e0206519.
    PubMed     Text format     Abstract available


  93. SHAH MS, DeSantis T, Yamal JM, Weir T, et al
    Re-purposing 16S rRNA gene sequence data from within case paired tumor biopsy and tumor-adjacent biopsy or fecal samples to identify microbial markers for colorectal cancer.
    PLoS One. 2018;13:e0207002.
    PubMed     Text format     Abstract available


    January 2017
  94. SIEBENKAS C, Chiappinelli KB, Guzzetta AA, Sharma A, et al
    Inhibiting DNA methylation activates cancer testis antigens and expression of the antigen processing and presentation machinery in colon and ovarian cancer cells.
    PLoS One. 2017;12:e0179501.
    PubMed     Text format     Abstract available


  95. BOOT A, Oosting J, van Eendenburg JDH, Kuppen PJK, et al
    Methylation associated transcriptional repression of ELOVL5 in novel colorectal cancer cell lines.
    PLoS One. 2017;12:e0184900.
    PubMed     Text format     Abstract available


  96. ZHAN Z, Verberne CJ, van den Heuvel ER, Grossmann I, et al
    Psychological effects of the intensified follow-up of the CEAwatch trial after treatment for colorectal cancer.
    PLoS One. 2017;12:e0184740.
    PubMed     Text format     Abstract available


  97. OSTENSSON E, Silfverschiold M, Greiff L, Asciutto C, et al
    The economic burden of human papillomavirus-related precancers and cancers in Sweden.
    PLoS One. 2017;12:e0179520.
    PubMed     Text format     Abstract available


  98. WANG B, Yang J, Li S, Lv M, et al
    Tumor location as a novel high risk parameter for stage II colorectal cancers.
    PLoS One. 2017;12:e0179910.
    PubMed     Text format     Abstract available


  99. KURACHA MR, Thomas P, Loggie BW, Govindarajan V, et al
    Bilateral blockade of MEK- and PI3K-mediated pathways downstream of mutant KRAS as a treatment approach for peritoneal mucinous malignancies.
    PLoS One. 2017;12:e0179510.
    PubMed     Text format     Abstract available


  100. LI Z, Li SA, Sun Y, Liu Y, et al
    TNF-alpha -308 A allele is associated with an increased risk of distant metastasis in rectal cancer patients from Southwestern China.
    PLoS One. 2017;12:e0178218.
    PubMed     Text format     Abstract available


  101. IWATA T, Uchino T, Koyama A, Johmura Y, et al
    The G2 checkpoint inhibitor CBP-93872 increases the sensitivity of colorectal and pancreatic cancer cells to chemotherapy.
    PLoS One. 2017;12:e0178221.
    PubMed     Text format     Abstract available


  102. PENG YC, Lin CL, Sung FC
    The association between cholecystectomy and colorectal neoplasm in inflammatory bowel diseases: A population-based cohort study.
    PLoS One. 2017;12:e0177745.
    PubMed     Text format     Abstract available


  103. LAMBERTI MJ, Pansa MF, Vera RE, Fernandez-Zapico ME, et al
    Transcriptional activation of HIF-1 by a ROS-ERK axis underlies the resistance to photodynamic therapy.
    PLoS One. 2017;12:e0177801.
    PubMed     Text format     Abstract available


  104. DE WIT M, Carvalho B, Delis-van Diemen PM, van Alphen C, et al
    Lumican and versican protein expression are associated with colorectal adenoma-to-carcinoma progression.
    PLoS One. 2017;12:e0174768.
    PubMed     Text format     Abstract available


  105. COEBERGH VAN DEN BRAAK RRJ, Sieuwerts AM, Kandimalla R, Lalmahomed ZS, et al
    High mRNA expression of splice variant SYK short correlates with hepatic disease progression in chemonaive lymph node negative colon cancer patients.
    PLoS One. 2017;12:e0185607.
    PubMed     Text format     Abstract available


  106. NIIKURA R, Hirata Y, Suzuki N, Yamada A, et al
    Colonoscopy reduces colorectal cancer mortality: A multicenter, long-term, colonoscopy-based cohort study.
    PLoS One. 2017;12:e0185294.
    PubMed     Text format     Abstract available


  107. SLIK K, Kurki S, Korpela T, Carpen O, et al
    Ezrin expression combined with MSI status in prognostication of stage II colorectal cancer.
    PLoS One. 2017;12:e0185436.
    PubMed     Text format     Abstract available


  108. XU R, Lin L, Li Y, Li Y, et al
    ShenQi FuZheng Injection combined with chemotherapy in the treatment of colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0185254.
    PubMed     Text format     Abstract available


  109. HILSDEN RJ, Bridges R, Dube C, Heitman SJ, et al
    Scheduling rules for patients with diabetes mellitus that facilitate split-dosing improve the quality of bowel preparation for colonoscopy.
    PLoS One. 2017;12:e0182225.
    PubMed     Text format     Abstract available


  110. HOCHMAN G, Halevi-Tobias K, Kogan Y, Agur Z, et al
    Extracellular inhibitors can attenuate tumorigenic Wnt pathway activity in adenomatous polyposis coli mutants: Predictions of a validated mathematical model.
    PLoS One. 2017;12:e0179888.
    PubMed     Text format     Abstract available


  111. HENNENBERG EM, Eyking A, Reis H, Cario E, et al
    MDR1A deficiency restrains tumor growth in murine colitis-associated carcinogenesis.
    PLoS One. 2017;12:e0180834.
    PubMed     Text format     Abstract available


  112. KIRCHNER J, Sawicki LM, Deuschl C, Gruneisen J, et al
    18 F-FDG PET/MR imaging in patients with suspected liver lesions: Value of liver-specific contrast agent Gadobenate dimeglumine.
    PLoS One. 2017;12:e0180349.
    PubMed     Text format     Abstract available


  113. BLAGOEV KB, Wilkerson J, Burotto M, Kim C, et al
    Neutral evolution of drug resistant colorectal cancer cell populations is independent of their KRAS status.
    PLoS One. 2017;12:e0175484.
    PubMed     Text format     Abstract available


  114. CHOI YJ, Lee DH, Han KD, Kim HS, et al
    The relationship between drinking alcohol and esophageal, gastric or colorectal cancer: A nationwide population-based cohort study of South Korea.
    PLoS One. 2017;12:e0185778.
    PubMed     Text format     Abstract available


  115. LIN GL, Ting HJ, Tseng TC, Juang V, et al
    Modulation of the mRNA-binding protein HuR as a novel reversal mechanism of epirubicin-triggered multidrug resistance in colorectal cancer cells.
    PLoS One. 2017;12:e0185625.
    PubMed     Text format     Abstract available


  116. MORUZZI S, Guarini P, Udali S, Ruzzenente A, et al
    One-carbon genetic variants and the role of MTHFD1 1958G>A in liver and colon cancer risk according to global DNA methylation.
    PLoS One. 2017;12:e0185792.
    PubMed     Text format     Abstract available


  117. TSENG JC, Narayanan N, Ho G, Groves K, et al
    Fluorescence imaging of bombesin and transferrin receptor expression is comparable to 18F-FDG PET in early detection of sorafenib-induced changes in tumor metabolism.
    PLoS One. 2017;12:e0182689.
    PubMed     Text format     Abstract available


  118. LI P, Xiao Z, Braciak TA, Ou Q, et al
    Systematic immunohistochemical screening for mismatch repair and ERCC1 gene expression from colorectal cancers in China: Clinicopathological characteristics and effects on survival.
    PLoS One. 2017;12:e0181615.
    PubMed     Text format     Abstract available


  119. GASLJEVIC G, Edhemovic I, Cemazar M, Brecelj E, et al
    Histopathological findings in colorectal liver metastases after electrochemotherapy.
    PLoS One. 2017;12:e0180709.
    PubMed     Text format     Abstract available


  120. MURPHY C, Rettedal E, Lehouritis P, Devoy C, et al
    Intratumoural production of TNFalpha by bacteria mediates cancer therapy.
    PLoS One. 2017;12:e0180034.
    PubMed     Text format     Abstract available


  121. RIVA A, BOrgesen M, Guldmann-Christensen M, Hauge Kyneb M, et al
    SensiScreen(R)KRAS exon 2-sensitive simplex and multiplex real-time PCR-based assays for detection of KRAS exon 2 mutations.
    PLoS One. 2017;12:e0178027.
    PubMed     Text format     Abstract available


  122. SINN DH, Min YW, Son HJ, Rhee PL, et al
    Metabolically-healthy obesity is associated with higher prevalence of colorectal adenoma.
    PLoS One. 2017;12:e0179480.
    PubMed     Text format     Abstract available


  123. JUNG SY, Rohan T, Strickler H, Bea J, et al
    Genetic variants and traits related to insulin-like growth factor-I and insulin resistance and their interaction with lifestyles on postmenopausal colorectal cancer risk.
    PLoS One. 2017;12:e0186296.
    PubMed     Text format     Abstract available


  124. LI Y, Li J, Liu H, Liu Y, et al
    Correction: Expression of MYSM1 is associated with tumor progression in colorectal cancer.
    PLoS One. 2017;12:e0186530.
    PubMed     Text format     Abstract available


  125. CHEE CG, Kim YH, Lee KH, Lee YJ, et al
    CT texture analysis in patients with locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy: A potential imaging biomarker for treatment response and prognosis.
    PLoS One. 2017;12:e0182883.
    PubMed     Text format     Abstract available


  126. DIAO R, Mu X, Wang T, Li S, et al
    Risk score based on ten lncRNA-mRNA expression predicts the survival of stage II-III colorectal carcinoma.
    PLoS One. 2017;12:e0182908.
    PubMed     Text format     Abstract available


  127. YANG YJ, Bang CS, Shin SP, Baik GH, et al
    Clinical impact of non-alcoholic fatty liver disease on the occurrence of colorectal neoplasm: Propensity score matching analysis.
    PLoS One. 2017;12:e0182014.
    PubMed     Text format     Abstract available


  128. PEARCE A, Haas M, Viney R, Pearson SA, et al
    Incidence and severity of self-reported chemotherapy side effects in routine care: A prospective cohort study.
    PLoS One. 2017;12:e0184360.
    PubMed     Text format     Abstract available


  129. DARLING NJ, Balmanno K, Cook SJ
    ERK1/2 signalling protects against apoptosis following endoplasmic reticulum stress but cannot provide long-term protection against BAX/BAK-independent cell death.
    PLoS One. 2017;12:e0184907.
    PubMed     Text format     Abstract available


  130. KAWAKUBO M, Demehri S, Manstein D
    Fractional laser exposure induces neutrophil infiltration (N1 phenotype) into the tumor and stimulates systemic anti-tumor immune response.
    PLoS One. 2017;12:e0184852.
    PubMed     Text format     Abstract available


  131. HUANG JY, Wang R, Gao YT, Yuan JM, et al
    ABO blood type and the risk of cancer - Findings from the Shanghai Cohort Study.
    PLoS One. 2017;12:e0184295.
    PubMed     Text format     Abstract available


  132. KUMARASAMY V, Kuppusamy UR, Jayalakshmi P, Samudi C, et al
    Exacerbation of colon carcinogenesis by Blastocystis sp.
    PLoS One. 2017;12:e0183097.
    PubMed     Text format     Abstract available


  133. OLSSON PO, Kalamajski S, Maccarana M, Oldberg A, et al
    Fibromodulin deficiency reduces collagen structural network but not glycosaminoglycan content in a syngeneic model of colon carcinoma.
    PLoS One. 2017;12:e0182973.
    PubMed     Text format     Abstract available


  134. YOKOYAMA S, Takeuchi A, Yamaguchi S, Mitani Y, et al
    Clinical implications of carcinoembryonic antigen distribution in serum exosomal fraction-Measurement by ELISA.
    PLoS One. 2017;12:e0183337.
    PubMed     Text format     Abstract available


  135. GORFINE M, Berndt SI, Chang-Claude J, Hoffmeister M, et al
    Heritability Estimation using a Regularized Regression Approach (HERRA): Applicable to continuous, dichotomous or age-at-onset outcome.
    PLoS One. 2017;12:e0181269.
    PubMed     Text format     Abstract available


  136. PRABHU VV, Lulla AR, Madhukar NS, Ralff MD, et al
    Cancer stem cell-related gene expression as a potential biomarker of response for first-in-class imipridone ONC201 in solid tumors.
    PLoS One. 2017;12:e0180541.
    PubMed     Text format     Abstract available


  137. XU Q, Tong JL, Zhang CP, Xiao Q, et al
    miR-27a induced by colon cancer cells in HLECs promotes lymphangiogenesis by targeting SMAD4.
    PLoS One. 2017;12:e0186718.
    PubMed     Text format     Abstract available


  138. LEI S, Ding Y, Fu Y, Wu S, et al
    The preclinical analysis of TW-37 as a potential anti-colorectal cancer cell agent.
    PLoS One. 2017;12:e0184501.
    PubMed     Text format     Abstract available


  139. PRALL F, Maletzki C, Huhns M, Krohn M, et al
    Colorectal carcinoma tumour budding and podia formation in the xenograft microenvironment.
    PLoS One. 2017;12:e0186271.
    PubMed     Text format     Abstract available


  140. JUAREZ M, Egoavil C, Rodriguez-Soler M, Hernandez-Illan E, et al
    KRAS and BRAF somatic mutations in colonic polyps and the risk of metachronous neoplasia.
    PLoS One. 2017;12:e0184937.
    PubMed     Text format     Abstract available


  141. MANIKIS GC, Marias K, Lambregts DMJ, Nikiforaki K, et al
    Diffusion weighted imaging in patients with rectal cancer: Comparison between Gaussian and non-Gaussian models.
    PLoS One. 2017;12:e0184197.
    PubMed     Text format     Abstract available


  142. HONG SN, Son HJ, Choi SK, Chang DK, et al
    A prediction model for advanced colorectal neoplasia in an asymptomatic screening population.
    PLoS One. 2017;12:e0181040.
    PubMed     Text format     Abstract available


  143. SCOTT AJ, Song EK, Bagby S, Purkey A, et al
    Evaluation of the efficacy of dasatinib, a Src/Abl inhibitor, in colorectal cancer cell lines and explant mouse model.
    PLoS One. 2017;12:e0187173.
    PubMed     Text format     Abstract available


  144. ROSWALL N, Bidstrup PE, Raaschou-Nielsen O, Solvang Jensen S, et al
    Residential road traffic noise exposure and colorectal cancer survival - A Danish cohort study.
    PLoS One. 2017;12:e0187161.
    PubMed     Text format     Abstract available


  145. MYUNG DS, Kweon SS, Lee J, Shin IS, et al
    Clinicopathological features of laterally spreading colorectal tumors and their association with advanced histology and invasiveness: An experience from Honam province of South Korea: A Honam Association for the Study of Intestinal Diseases (HASID).
    PLoS One. 2017;12:e0184205.
    PubMed     Text format     Abstract available


  146. BRAND EC, Crook JE, Thomas CS, Siersema PD, et al
    Development and validation of a prediction model for adenoma detection during screening and surveillance colonoscopy with comparison to actual adenoma detection rates.
    PLoS One. 2017;12:e0185560.
    PubMed     Text format     Abstract available


  147. YU Z, Chen Z, Wu J, Li Z, et al
    Prognostic value of pretreatment serum carbohydrate antigen 19-9 level in patients with colorectal cancer: A meta-analysis.
    PLoS One. 2017;12:e0188139.
    PubMed     Text format     Abstract available


  148. PARK H, Cho S, Woo H, Park SK, et al
    Fasting glucose and risk of colorectal cancer in the Korean Multi-center Cancer Cohort.
    PLoS One. 2017;12:e0188465.
    PubMed     Text format     Abstract available


  149. BIEN SA, Auer PL, Harrison TA, Qu C, et al
    Enrichment of colorectal cancer associations in functional regions: Insight for using epigenomics data in the analysis of whole genome sequence-imputed GWAS data.
    PLoS One. 2017;12:e0186518.
    PubMed     Text format     Abstract available


  150. HUO T, Canepa R, Sura A, Modave F, et al
    Colorectal cancer stages transcriptome analysis.
    PLoS One. 2017;12:e0188697.
    PubMed     Text format     Abstract available


  151. ROVELLI C, Poli A, Galli L, Cernuschi M, et al
    Presence of multiple genotypes in subjects with HPV-16 infection is highly associated with anal squamous intraepithelial lesions in HIV-1 infected males.
    PLoS One. 2017;12:e0186367.
    PubMed     Text format     Abstract available


  152. ZHANG Z, Zheng F, Yu Z, Hao J, et al
    XRCC5 cooperates with p300 to promote cyclooxygenase-2 expression and tumor growth in colon cancers.
    PLoS One. 2017;12:e0186900.
    PubMed     Text format     Abstract available


  153. HWANG IC, Chang J, Park SM
    Emerging hazard effects of proton pump inhibitor on the risk of colorectal cancer in low-risk populations: A Korean nationwide prospective cohort study.
    PLoS One. 2017;12:e0189114.
    PubMed     Text format     Abstract available


  154. BERRY RS, Xiong MJ, Greenbaum A, Mortaji P, et al
    High levels of tumor-associated neutrophils are associated with improved overall survival in patients with stage II colorectal cancer.
    PLoS One. 2017;12:e0188799.
    PubMed     Text format     Abstract available


  155. LORCA V, Rueda D, Martin-Morales L, Poves C, et al
    Role of GALNT12 in the genetic predisposition to attenuated adenomatous polyposis syndrome.
    PLoS One. 2017;12:e0187312.
    PubMed     Text format     Abstract available


  156. HOEDJES M, de Kruif A, Mols F, Bours M, et al
    An exploration of needs and preferences for dietary support in colorectal cancer survivors: A mixed-methods study.
    PLoS One. 2017;12:e0189178.
    PubMed     Text format     Abstract available


  157. SERRANO-VILLAR S, Hernandez-Novoa B, de Benito A, Del Romero J, et al
    Screening for precancerous anal lesions with P16/Ki67 immunostaining in HIV-infected MSM.
    PLoS One. 2017;12:e0188851.
    PubMed     Text format     Abstract available


  158. GRAF JF, Zavodszky MI
    Characterizing the heterogeneity of tumor tissues from spatially resolved molecular measures.
    PLoS One. 2017;12:e0188878.
    PubMed     Text format     Abstract available


  159. MA L, Wang L, Shan Y, Nafees M, et al
    Suppression of cancer stemness by upregulating Ligand-of-Numb protein X1 in colorectal carcinoma.
    PLoS One. 2017;12:e0188665.
    PubMed     Text format     Abstract available


  160. ANANTHARAJU PG, Reddy DB, Padukudru MA, Chitturi CMK, et al
    Induction of colon and cervical cancer cell death by cinnamic acid derivatives is mediated through the inhibition of Histone Deacetylases (HDAC).
    PLoS One. 2017;12:e0186208.
    PubMed     Text format     Abstract available


  161. VIRGONE-CARLOTTA A, Lemasson M, Mertani HC, Diaz JJ, et al
    In-depth phenotypic characterization of multicellular tumor spheroids: Effects of 5-Fluorouracil.
    PLoS One. 2017;12:e0188100.
    PubMed     Text format     Abstract available


  162. KO Y, Kim J, Park JK, Kim H, et al
    Limited detection of small (</= 10 mm) colorectal liver metastasis at preoperative CT in patients undergoing liver resection.
    PLoS One. 2017;12:e0189797.
    PubMed     Text format     Abstract available


  163. KOENIG A, Krug S, Mueller D, Barth PJ, et al
    Clinicopathological hallmarks and biomarkers of colorectal neuroendocrine neoplasms.
    PLoS One. 2017;12:e0188876.
    PubMed     Text format     Abstract available


  164. OSMAN M, Benamrouz S, Guyot K, Baydoun M, et al
    High association of Cryptosporidium spp. infection with colon adenocarcinoma in Lebanese patients.
    PLoS One. 2017;12:e0189422.
    PubMed     Text format     Abstract available


  165. GONG J, Bai T, Zhang L, Qian W, et al
    Inhibition effect of Bifidobacterium longum, Lactobacillus acidophilus, Streptococcus thermophilus and Enterococcus faecalis and their related products on human colonic smooth muscle in vitro.
    PLoS One. 2017;12:e0189257.
    PubMed     Text format     Abstract available


  166. O'NEIL BH, Wallmark JM, Lorente D, Elez E, et al
    Safety and antitumor activity of the anti-PD-1 antibody pembrolizumab in patients with advanced colorectal carcinoma.
    PLoS One. 2017;12:e0189848.
    PubMed     Text format     Abstract available


Thank you for your interest in scientific medicine.


AMEDEO Colorectal Neoplasms is free of charge.
This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim.

Design: